The global animal model market size was US$ 1,577.3 million in 2021. The global animal model market is forecast to grow to US$ 2,676.8 million by 2030 by growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2022 to 2030.
Animal models are used by scientists to study & develop the cure for diseases. In this process, final medicinal drugs are tested on animals before carried out the test on humans.
Factors Influencing the Market
The wide range of research activities to develop novel drugs will fuel the growth of the global animal model market. Furthermore, an increase in the adoption of CRISPR technology is expected to offer ample growth opportunities for market growth. The CRISPR technology (Clustered Regularly Interspaced Short Palindromic Repeats) is a time-saving procedure process than conventional technique, which will benefit the animal model market.
The model allows the production of mutant models, such as mutant mouse models, which are highly difficult using conventional technology. As a result, it will surge the growth of the animal model market during the study period.
Stringent regulations related to the use of animals in research may limit the growth of the animal model market. On the contrary, growing investments and other initiatives to boost healthcare infrastructure will further boost the growth of the animal model market during the study period.
COVID-19 Impact Analysis
The wake of the COVID-19 pandemic has surged the range of R&D activities due to varied symptoms and variants. Thus, it also increased the demand for animal models. Moreover, the ongoing pandemic is substantially increasing the demand for more efficient vaccines and models. Thus, it will drive the animal model market forward even in the coming years.
Regional Analysis
The Asia-Pacific animal model market is forecast to emerge as the largest market, owing to the growing preference for animal testing in R&D activities. Furthermore, government support for the development of new novel drugs will also benefit the animal model market during the study period.
Growing implications of mouse clinical trials (MCTs) and ongoing investments in the research activities will benefit the animal model market. The Asia-Pacific animal model market is expected to witness substantial growth opportunities due to the growing range of innovations, the availability of advanced healthcare systems and the rise in pre-clinical activities by CROs. Thus, all of these factors will drive the animal model market forward.
Competitors in the Market
Market Segmentation
By Animal Type Outlook
By Application Outlook
By End-Users Outlook
By Regional Outlook
